Label-free electrochemical biosensor with magnetically induced self-assembly for the detection of cancer antigen 125

Magnetically induced self-assembly technology was used to construct a label-free electrochemical biosensor based on magnetic Mg0.5Cu0.5Fe2O4-Au nanocomposites for the sensitive detection of cancer antigen 125 (CA125). To aim for this, Mg0.5Cu0.5Fe2O4 nanoparticles were first prepared via the rapid combustion process. The average diameter of the nanoparticles calcined at 800 °C with the absolute ethanol volume of 20 mL was about 169.3 nm. Then Au was used for the surface modification by NaBH4 reduction reaction approach. The magnetic glassy carbon electrode (MGCE) was modified by Mg0.5Cu0.5Fe2O4-Au via a magnetic induction self-assembly process. The reduced thiol-modified single-stranded DNA was attached to the Mg0.5Cu0.5Fe2O4-Au nanocomposites by Au-S bonds without any coupling agent. CA125 antigen was grabbed directly by its aptamer DNA due to its specific identification with the aptamer. Finally, the modified electrodes were blocked with BSA and then characterized. Finally, DPV analysis was used for CA125 detection, the novel fabricated biosensor demonstrated good detection properties for CA125 with a linear range of 5–125 U/mL and a detection limit of 4.4 U/mL. The results showed that the aptamer sensor had good specificity, repeatability, and stability. The feasibility of our sensor for the determination of CA125 was also demonstrated by measuring CA125 levels in serum using the Roche gold-standard instrument of the People’s Hospital of Danyang as the reference value. The recoveries of real serum samples were 94.65–101.71%, and RSDs were 1.26–4.65%. Moreover, the surface of the electrode could be cleaned and reused by magnetic separation, greatly reducing the cost and providing the possibility for a point-of-care test (POCT). This work demonstrated a new strategy for integrating both nanostructures and biocompatibility to build advanced cancer biomarker sensors with wide applications.